All filters
Slidesets
HIV reservoir dynamics: Implications for HIV latency establishment and reversal | Deanna Kulpa, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Baricitinib reverses HIV associated neurocognitive disorders and reservoir seeding in a SCID mouse model | Christina Gavegnano, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
State of the Art Lecture: Harnessing the immune system to eliminate and/or control HIV | Steven Deeks, MD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Potential for HIV cure by stem cell transplantation (IciStem) | Monique Nijhuis, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Differential detection of M184V/I between plasma historical HIV genotypes and proviral DNA from PBMCs (#3) | Nicolas Margot
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Oral ABX464 has a dose dependent reduction in the HIV-1 DNA reservoir in CD4+ Peripheral Blood T Cells (#2) | Jean-Marc Steens
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Presentation of Barry-Wainberg DART Achievement Award and recipient | Charles Boucher, MD, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
State of the Art Lecture: Rational design of doravirine (DOR): From bench to patients | Daria Hazuda, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Injectable ART: Advantages and disadvantages | Michael Saag, MD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
A post-transcriptional feedback mechanism for noise suppression and fate stabilization | Leor Weinberger, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Barry-Wainberg DART Achievement Award Lecture: Overview of the research conducted at the Irsicaixa Foundation | Bonaventura Clotet, MD, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Difficulties and barriers in developing RSV polymerase inhibitors | Rachel Fearns, PhD
Presented at:
RespiDART 2018
Slidesets
Abstract: SB 9200 is a novel broad-spectrum antiviral agent effective against both RSV and Flu (#101) | Diane Schmidt
Presented at:
RespiDART 2018
Slidesets
Abstract: Structure-based prediction of influenza resistance mutations (#102) | Bryan Cox
Presented at:
RespiDART 2018
Slidesets
3D Human epithelial models to study respiratory virus pathogenesis | Samuel Constant, PhD
Presented at:
RespiDART 2018
Slidesets
Abstract: Risk factors for RSV severity in immunocompetent and immunocompromised adults presenting in an emergency department (#103) | Slim Fourati
Presented at:
RespiDART 2018
Slidesets
Abstract: Non-targeted diagnosis of multiple viral infections by means of shotgun metagenomic using deep sequencing (#104) | Slim Fourati, PhD
Presented at:
RespiDART 2018
Slidesets
Plenary Lecture: Opportunities and Challenges for a Broadly Protective Influenza Vaccine | Gary Nabel, MD
Presented at:
RespiDART 2018
Slidesets
RV521: A new and potent RSV fusion inhibitor in clinical development | Stuart Cockerill, PhD
Presented at:
RespiDART 2018
Slidesets
Cocrystal Pharma: Influenza drug pipeline design | Sam Lee, PhD
Presented at:
RespiDART 2018
Slidesets
Discovery and development of novel and potent non-fusion inhibitors of RSV | Michael Rhodin, PhD
Presented at:
RespiDART 2018
Slidesets
Use of Integrase Inhibitors in special populations | Omar Sued, MSc, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Clinical use of Integrase Inhibitors | Eugenia Negredo, PhD
Presented at:
Argentina HIV Clinical Forum 2018